Recalls / Class II
Class IID-1308-2019
Product
Bevacizumab 2.5 mg/0.1 mL, packaged in a Prefilled Syringe, Rx only, AVELLA SPECIALTY PHARMACY 24416 N. 19TH AVENUE PHOENIX, AZ 85085, NDC 42852-001-27
- Affected lot / code info
- Lot #: 138-20191202@64, Exp 05/13/19
Why it was recalled
Lack of assurance of sterility
Recalling firm
- Firm
- Avella of Deer Valley, Inc. Store 38
- Notification channel
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
- Type
- Voluntary: Firm initiated
- Address
- 24416 N 19th Ave, N/A, Phoenix, Arizona 85085-1887
Distribution
- Quantity
- 730 syringes
- Distribution pattern
- U.S.A. nationwide
Timeline
- Recall initiated
- 2019-05-03
- FDA classified
- 2019-05-29
- Posted by FDA
- 2019-06-05
- Terminated
- 2020-02-25
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-1308-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.